The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.

The Rx Pain Medications. Know the Options. Get the Facts. is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management. This particular fact sheet focuses on using Naloxone as a deterrent to overdose.

The Rx Pain Medications. Know the Options. Get the Facts. is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management. This particular fact sheet focuses on patients requiring assistance with ineffective medications.

This manual offers best practices to states, tribes, and local communities on collaborative treatment approaches for pregnant women living with opioid use disorders, and the risks and benefits associated with medication-assisted treatment.

This guide educates substance use counselors and clinicians about detoxification and withdrawal. It addresses patient placement, detox services for specific substances, co-occurring disorders, financing issues, and screening and assessment tools.

This comic book presents basic information about hepatitis C for people living with mental illness or substance use disorders. It uses plain language and a simple cartoon style to explain what hepatitis C is, how to avoid it, the screening process, and treatment options.

This brochure is for family members of people living with substance use disorders. It answers questions about substance use disorders, their symptoms, different types of treatment, and recovery. The brochure also addresses concerns of children of parents living with substance use disorders.

This quick guide helps clinicians address viral hepatitis when working with people living with substance use disorders. It covers hepatitis prevention, screening, treatment, and service coordination, and guides administrators on how to add or improve hepatitis services.

This manual helps clinicians improve care for people living with HIV/AIDS and substance use disorder conditions. It discusses prevention, assessment, and treatment of HIV/AIDS. The manual also examines mental illness, integrated services, case management, counseling, ethical and legal issues, and funding sources.